Press Releases and News

AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019

February 15, 2019

The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Our AQS3proTM  was a cutting edge addition … “AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019”

RedShiftBio’s  AQS³pro: Finalist in The Prism Awards 2019

January 30, 2019

RedShift™ BioAnalytics, Inc. (RedShiftBio™) announces that the AQS3pro has been named as a finalist in the Prism Awards 2019. The Prism Awards recognize outstanding examples and innovative products that are changing lives for the better. This year was quoted by one of the judges to be “an exceptional year of exceptional products”.

Complex Protein Studies Demand Dynamic Techniques

October 5, 2018

Biopharm International interviews scientists with experience of Microfluidic Modulation Spectroscopy for a round-table on how complex protein studies demand dynamic techniques. Visit page 18 to see what Immunogen, Janssen, Elion Labs and the University of Delaware have to say.

Immunogen presents MMS data in talk at Bioprocessing Summit

August 26, 2018

Our team recently joined  international bioprocess professionals at the Bioprocessing Summit, where we discussed practical solutions for bioprocess challenges. Karan Shah, Principal Development Associate, Analytical and Pharmaceutical Sciences, ImmunoGen, gave a great talk on our Modulation Spectrometry (MMS) technique. He presented a comparison of his MMS results with conventional analytical approaches. If you are interested … “Immunogen presents MMS data in talk at Bioprocessing Summit”

Workshop on Protein Aggregation and Immunogenicity in Colorado

August 17, 2018

The RedShiftBio team has just returned from Colorado where we attended a great workshop on aggregation and immunogenicity. Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding the role of aggregates during immunogenicity of therapeutic protein products is critical, and therefore was the Workshop focus.  Our AQS3pro … “Workshop on Protein Aggregation and Immunogenicity in Colorado”

RedShiftBio Strengthens Focus on Applications with New Hire

August 17, 2018

Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid proteins and aggregation: key applications for many users of the Microfluidic Modulation Spectroscopy (MMS)-based AQS3pro.